Vacuna “marcadora” contra el HVB-1
Investigadores del INTA trabajaron en el desarrollo de un producto que previene una enfermedad que provoca importantes pérdidas económicas y que permite diferenciar entre animales vacunados e infectados.
| Autor principal: | |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Español |
| Publicado: |
Gerencia de Comunicación e Imagen Institucional, DNA SICC, INTA
2019
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/6382 |
Ejemplares similares: Vacuna “marcadora” contra el HVB-1
- Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle
- Evidence of natural interspecific recombinant viruses between bovine alphaherpesviruses 1 and 5
- A plasmid encoding the extracellular domain of CD40 ligand and MontanideTM GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1
- An improved DNA vaccine against bovine herpesvirus-1 using CD40L and a chemical adjuvant induces specific cytotoxicity in mici
- A new method for simultaneous detection and discrimination of Bovine herpesvirus types 1 (BoHV-1) and 5 (BoHV-5) using real time PCR with high resolution melting (HRM) analysis
- Distribution of bovine herpesvirus type 1 in the nervous system of experimentally infected calves